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ABSTRACT 1 
 2 
Lactobacillus rhamnosus GG  is  a  well-established  Gram-positive  probiotic  strain,  whose  3 
health-benefiting properties are in part dependent upon a prolonged residency in the 4 
gastrointestinal tract and likely dictated by an adherence to the intestinal mucosa.  Previously, 5 
we identified two pilus gene clusters (spaCBA and spaFED) in the genome of this probiotic, 6 
each of which contained the predicted genes for three pilin subunits and a single sortase.  We 7 
also  confirmed  the  presence  of  SpaCBA  pili  on  the  cell  surface  and  attributed  an  intestinal  8 
mucus-binding capacity to one of the pilin subunits (SpaC).  Herein, we now report the 9 
cloning of the remaining pilin genes (spaA, spaB, spaD, spaE, and spaF) in Escherichia coli, 10 
production and purification of the recombinant proteins, and an assessment of their adherence 11 
to human intestinal mucus.  Our findings indicate that the SpaB and SpaF pilin subunits also 12 
exhibit substantial mucus binding, which can be inhibited competitively in a dose-related 13 
manner.  Moreover, the binding between SpaB pilin subunit and the mucosal substrate 14 
appears to operate through electrostatic contacts and is not related to a recognized mucus-15 
binding domain.  We conclude from these results that it is conceivable two pilin subunits 16 
(SpaB and SpaC) in the SpaCBA pilus fiber play a role in binding to intestinal mucus, but for 17 
the uncharacterized and putative SpaFED pilus fiber only a single pilin subunit (SpaF) is 18 
potentially responsible for mucus adhesion. 19 
 20 
 21 
 22 
 23 
 24 
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INTRODUCTION 1 
 2 
The human intestinal microbiota is comprised of more than 1000 species of commensal and 3 
probiotic bacteria, including several members of the Gram-positive genus Lactobacillus (42, 4 
52).  Many strains of lactobacilli display a variety of health-promoting effects in humans and 5 
consequently are commercialized for use as probiotics in foods and nutritional supplements 6 
(reviewed in 48).  Often a necessary precondition for probiotic bacteria colonization of the 7 
human gastrointestinal (GI) tract is a preferential adherence to the intestinal mucosa, which in 8 
turn prolongs and stabilizes intestinal residency, possibly then triggering a variety of 9 
defensive host cell immune responses and excluding pathogenic bacteria by competitive 10 
inhibition or steric hindrance (48).  The outermost layer of the intestinal mucosa, a secreted 11 
and hydrated mucus gel acting as a protective barrier and filter, consists primarily of a 12 
heterogeneous mix of highly glycosylated membrane-associated and secreted glycoproteins 13 
called mucins (36).  Although many studies have demonstrated that various probiotic 14 
Lactobacillus spp. adhere initially to the mucus gel layer relatively few details are known 15 
about the overall molecular mechanism of mucosal adhesion (reviewed in 23).  Nonetheless, 16 
several studies have reported that the adherence of Lactobacillus cells to the mucosal barrier 17 
is  frequently  a  surface  protein-mediated  interaction.   For  example,  Rojas  et  al.  (44)  18 
determined that the ability of Lactobacillus fermentum 104R  (since  reclassified  as  19 
Lactobacillus reuteri 104R) to bind porcine small intestinal mucus and gastric mucin was 20 
facilitated by the cell surface-localized mucus adhesion promoting protein (MapA).  21 
Similarly, Macías-Rodríguez et al. (25) described the presence of two adhesion-associated 22 
proteins specific for porcine intestinal mucus-related substrates that are attached non-23 
covalently to the cell surface of Lactobacillus fermentum BCS87.  Roos and Jonsson (45) also 24 
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 5
demonstrated the adherence between the surface-associated Mub (mucus binding) protein 1 
from Lactobacillus reuteri 1063 and intestinal mucus components derived from porcine and 2 
poultry sources.  As well, Pretzer et al. (38) identified a large multidomain surface protein in 3 
Lactobacillus plantarum WCFS1 with a binding specificity for the mannose moieties in 4 
mucins.  Interestingly, Kinoshita et al. (19) discovered that glyceraldehyde-3-phosphate 5 
dehydrogenase (GAPDH), an enzyme associated normally with glycolysis, is localized on the 6 
surface of L. plantarum LA318 cells and adheres tightly to human colonic mucin. 7 
 8 
Until quite recently, only indirect or circumstantial evidence suggested that pilus-like 9 
structures extend from the surface of probiotic lactobacilli (28, 39).  However, in our previous 10 
study (18) we demonstrated that Lactobacillus rhamnosus GG, a well studied and widely used 11 
probiotic strain (48), is a piliated microbe.  Pili are slender elongated heteromeric 12 
proteinaceous surface appendages that exist in numerous other Gram-positive bacteria and 13 
often mediate adherence between both pathogenic and nonpathogenic species and their host 14 
cell targets (reviewed in 20, 26, 40, 49), but now emerge as possible adhesion facilitators for 15 
probiotic lactobacilli colonization of the GI tract (18).  Prototypically, the pilus fiber is 16 
composed of one major pilin that builds up the pilus backbone and two additional minor pilins 17 
(26, 40, 49), one subunit that has a role in signaling the cessation of pilus polymerization (27, 18 
39) and is deposited at the pilus base and at irregular intervals along the pilus backbone, and 19 
another subunit with an adhesive character that is often localized at the pilus tip (1, 41).  The 20 
current model of pilus assembly in Corynebacterium diphtheriae (27) suggests that each of 21 
these pilin subunits are connected covalently to one another through isopeptidyl bonds by a 22 
membrane-bound transpeptidase (pilin-specific sortase) to produce polymerized pili, which 23 
are then attached covalently to the cell wall by a different transpeptidase (the housekeeping 24 
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sortase) capable of recognizing all C-terminal LPXTG-like substrates.  The genes encoding 1 
these pilus proteins, as well as the pilin-specific sortase, are clustered at the same locus within 2 
the genome (54). 3 
 4 
In our recent study (18), we discovered that in the L. rhamnosus GG genome the pili-encoding 5 
genes for two different pilus fibers are arranged as the spaCBA and spaFED gene clusters 6 
and, based on a genomic comparison with another L. rhamnosus strain (LC705), that the 7 
spaCBA cluster was confined to only L. rhamnosus GG.  Moreover, in our previous work (18) 8 
each of the predicted genes for the major pilin subunit forming the pilus backbone (SpaA and 9 
SpaD),  one  ancillary  minor  pilin  subunit  (SpaB  and  SpaE)  that  based  on  a  model  for  pilus  10 
biogenesis is likely positioned at the pilus base and decorating the pilus backbone (27), and 11 
another larger sized minor pilin subunit considered adherent in nature (SpaC and SpaF) were 12 
identified in L. rhamnosus GG according to a shared amino acid identity with pilins from two 13 
enterococcal species.  In addition, we also detected within the sequences of the predicted 14 
spaCBA and spaFED gene products the anticipated consensus motifs and domains 15 
characteristic of a pilin primary structure, including the Sec-dependent secretion signal, 16 
sortase recognition site, YPKN pilin-like motif, and E box (18).  Subsequently, the expression 17 
and localization of intact SpaCBA pili on the cell surface of L. rhamnosus GG was confirmed 18 
in immunoblots and immunogold-labeled electron micrographs using antiserum specific for 19 
the SpaC pilin (18).  In earlier studies, adhesion interactions between the L. rhamnosus GG 20 
strain and intestinal mucosal surfaces have been reported and well characterized (15, 31, 33, 21 
46, 55-57).  However, in our recent study (18) the influence of SpaCBA pilus fibers in 22 
mediating the binding between L. rhamnosus GG cells and human intestinal mucus was 23 
revealed in adhesion experiments using both L. rhamnosus GG pretreated with SpaC 24 
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antiserum and a L. rhamnosus GG spaC insertion mutant.  More specifically, we 1 
demonstrated significant binding between recombinant SpaC pilin protein and intestinal 2 
mucus, thereby identifying a mucus-binding capacity for one of the minor pilin components 3 
localized at the tip and along the backbone of the SpaCBA pilus (18).  To expand further upon 4 
these findings, we now present a study in which each of the remaining predicted pilin subunits 5 
(SpaA, SpaB, SpaD, SpaE, and SpaF) in the spaCBA and spaFED gene  clusters  are  over-6 
produced in recombinant form, purified to apparent homogeneity, and characterized for 7 
adherence to human intestinal mucus. 8 
 9 
MATERIALS AND METHODS 10 
 11 
Bacterial strains, growth conditions, plasmids, and genomic DNA.  Escherichia coli 12 
strains TOP10 [F- mcrA D(mrr-hsdRMS-mcrBC) F80lacZDM15 DlacX74 recA1 araD139 13 
D(ara-leu)7697 galU galK rpsL (StrR) endA1 nupG] and BL21(DE3)pLysS [F- ompT 14 
hsdSB(rB-mB-) gal dcm (DE3) pLysS (CamR)] were used for cloning and expression, 15 
respectively.  E. coli was cultivated in Luria-Bertani (LB) medium with agitation at 37ºC and 16 
supplemented with 50 ?g/ml kanamycin as required.  The pET28b+ expression vector 17 
(Novagen) was used for cloning the Lactobacillus rhamnosus GG spaA, spaB, spaD, spaE, 18 
and spaF genes.   Genomic  DNA  was  isolated  from  L. rhamnosus GG (ATCC 53103) as 19 
described earlier (18).  Established protocols were employed in all DNA manipulations, 20 
including PCR amplifications, restriction endonuclease digests, ligations, and transformations, 21 
as described previously (47). 22 
 23 
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 8
Cloning of the L. rhamnosus GG SpaCBA and SpaFED pilin genes.  The coding sequence 1 
of  the  SpaCBA and SpaFED pilin  genes  was  obtained  from the  L. rhamnosus GG genomic 2 
sequence (18).  Each of the spaA, spaB, spaD, spaE, and spaF genes, without the region 3 
encoding the N-terminal secretion signal and the C-terminal sortase recognition site, was PCR 4 
amplified from L. rhamnosus GG  genomic  DNA  using  pairs  of  flanking  5'-  and  3'-end  5 
oligonucleotide primers (Oligomer, Finland) with an EcoRI site (a SacI site for spaF)  or  a  6 
XhoI site (see Table 1).  The respective PCR products were digested with EcoRI (or SacI for 7 
spaF) and XhoI restriction endonucleases, ligated into the similarly digested pET28b+ 8 
expression vector, and then transformed into E. coli TOP10.  The resultant expression 9 
plasmids (pKTH5319 for spaA, pKTH5320 for spaB, pKTH5324 for spaD, pKTH5379 for 10 
spaE, and pKTH5341 for spaF) were isolated and propagated in E. coli BL21(DE3)pLysS for 11 
intracellular production of C-terminal hexahistidine-tagged SpaCBA and SpaFED pilin 12 
proteins.  For each of the recombinant pilins, seven residues (nine residues for SpaF) at the N-13 
terminus and two residues preceding the C-terminal hexahistidine-tag originate from amino 14 
acids  encoded  by  the  expression  vector.   Cloning  of  the  spaC gene has been described 15 
elsewhere (18). 16 
 17 
Production and purification of recombinant SpaCBA and SpaFED pilin proteins.  For 18 
production and purification of recombinant SpaA, SpaB, SpaD, SpaE, and SpaF pilins, the 19 
procedure is essentially the same as reported for the isolation of the SpaC minor pilin (18).  In 20 
brief,  E. coli cells were grown at 37ºC to mid-log phase in LB medium containing 50 ?g/ml 21 
kanamycin, the protein expression induced for 3 h by 1 mM isopropyl ?-D-1-22 
thiogalactopyranoside (IPTG), and the cells recovered by centrifugation.  The pelleted cells 23 
were resupended in lysis buffer [50 mM NaH2PO4 (pH 8.0), 300 mM NaCl, 10 mM 24 
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imidazole] and the cell suspensions then disrupted using sonication followed by centrifugation 1 
and filtration (0.45 ?m) to produce clarified cell-free lysates. The hexahistidine-tagged pilin 2 
proteins (SpaA, SpaB, SpaD, SpaE, and SpaF) were then purified by using Ni2+-chelating 3 
affinity chromatography.  Each of the cell-free lysates was passed through a Ni-NTA agarose 4 
(Qiagen) column, which was rinsed extensively with wash buffer [50 mM NaH2PO4 (pH 8.0), 5 
300 mM NaCl, 20 mM imidazole] and the pilin proteins then removed with elution buffer [50 6 
mM NaH2PO4 (pH 8.0), 300 mM NaCl, 250 mM imidazole].  Elution fractions containing 7 
purified proteins were pooled and buffer-exchanged to 10 mM Tris-HCl (pH 8.0) for the 8 
SpaA, SpaD, SpaE, and SpaF pilins and to 50 mM sodium acetate (pH 5.1) for the SpaB pilin 9 
by using EconoPac 10 DG desalting columns (BioRad).  The recombinant pilins were 10 
concentrated using 10- or 30-kDa Microsep filters (Pall Life Sciences), the protein purity 11 
assessed by SDS-PAGE, and the protein concentration approximated by A280 measurements. 12 
 13 
Generation of SpaA and SpaB pilin-specific antibodies.  Antisera specific for L. 14 
rhamnosus GG SpaA and SpaB pilin proteins were generated using the same method 15 
described for producing SpaC antiserum (18).  In summary, rabbits received 1 ml 16 
subcutaneous (SC) injections containing 400 ?g purified recombinant SpaA or SpaB pilins 17 
mixed 1:1 with Freud’s complete adjuvant, and over three-week intervals a set of three 18 
subcutaneous booster injections (1 ml) of 200 ?g pilin protein in Freud’s incomplete adjuvant 19 
(1:1 mix).  Two weeks after the final booster injections, blood was collected for preparation of 20 
the SpaA and SpaB antiserum. 21 
 22 
Protein and whole cell radiolabeling.  Radiolabeling of pilin proteins with iodine-125 (125I) 23 
was carried out as described previously (18).  Pierce Iodination Reagent following the 24 
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 10
manufacturer’s protocol (Pierce) was used to radiolabel purified SpaA, SpaB, SpaC, SpaD, 1 
SpaE, and SpaF pilin proteins and ovalbumin (Sigma), and residual unbound radiolabel was 2 
removed chromatographically by using D-Salt™ Polyacrylamide Desalting Columns (Pierce).  3 
Metabolic radiolabeling of L. rhamnosus GG  cells  with  tritiated  thymidine  was  performed  4 
essentially as described earlier (58).  Briefly, L. rhamnosus GG was grown overnight in MRS 5 
broth containing 10 µl/ml [5'-3H] thymidine (16.7 Ci/nmol), the cells recovered by 6 
centrifugation, washed and resuspended in phosphate-buffered saline (PBS; pH 7.2), and the 7 
optical density of the culture suspension adjusted (A600 = 0.25) to normalize the number of 8 
cells.  9 
 10 
Isolation of human intestinal mucus.  Surgically removed tissue acquired from patients 11 
suffering from operable colorectal cancer and undergoing colonic resection was the source of 12 
intestinal mucus used for binding studies (32).  The recovery and use of resected human 13 
intestinal tissue was sanctioned by the ethics committee for the Hospital District of Southwest 14 
Finland and with the prior informed written consent of participating patients.  Intact mucosa-15 
containing resected tissue from noncancerous segments was chosen and the mucus layer 16 
extracted according to the method described earlier (58). 17 
 18 
Binding of radiolabeled SpaCBA and SpaFED pilins to intestinal mucus.  Saturating 19 
amounts of intestinal mucus were added to Maxisorp™ microtiter plate wells (Nunc), allowed 20 
to incubate overnight at 4ºC, washed extensively with PBS to remove unbound mucus, and 21 
incubated in blocking solution (0.5% bovine serum albumin in PBS) for 1 h at room 22 
temperature.  The blocking solution was aspirated away and 50 pmol radiolabeled SpaA, 23 
SpaB, SpaD, SpaE, or SpaF pilin subunits (each dissolved in blocking solution) were then 24 
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 11
added to wells containing immobilized mucus and incubated for 1 h at 37ºC.  After the wells 1 
were washed three times with PBS, the amount of protein-bound radioactivity (125I) was 2 
quantified using a Wallac 1480 WIZARD® 3" automatic gamma counter (PerkinElmer).  The 3 
mucus binding experiment was also performed with 50 pmol radiolabeled SpaC pilin (positive 4 
control) and ovalbumin (background control) 5 
 6 
Competitive inhibition of mucus binding by the SpaB and SpaF pilins.  Competitive 7 
binding of radiolabeled SpaB and SpaF pilins to mucus was carried using the procedure 8 
described earlier (18).  Using microtiter plate wells containing immobilized intestinal mucus 9 
(see above), 50 pmol radiolabeled SpaB or SpaF pilins (dissolved in blocking solution) were 10 
added to wells also containing 0, 100, 300, and 900 pmol competing amounts of unlabeled 11 
SpaB or  SpaF pilins  and  allowed to  incubate  for  1  h  at  37ºC.   The  wells  were  then  washed  12 
three  times  with  PBS  and  the  amount  of  bound  radioactive  (125I) protein measured with an 13 
automatic gamma counter.  As controls, 50 pmol radiolabeled SpaC pilin with competing 14 
protein (positive) and 50 pmol radiolabeled ovalbumin without competing protein 15 
(background) were also included in the competitive inhibition assay. 16 
 17 
Inhibition of binding between SpaB minor pilin and mucus.  Radiolabeled (125I) SpaB 18 
pilin (50 pmol) was pretreated with either 2.5 µg/µl lysozyme (Sigma) or near saturating 19 
quantities (~2.5 µg/µl) of unbound intestinal mucus and tested for binding to immobilized 20 
intestinal mucus according to the method described previously (see above).  As a control, the 21 
inhibition assay was also performed with 50 pmol radiolabeled SpaC pilin. 22 
 23 
 24 
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Antibody-mediated inhibition of L. rhamnosus GG  mucosal  adhesion.   Lactobacillus 1 
rhamnosus GG mucosal adhesion was inhibited by antiserum specific for SpaA and SpaB 2 
pilins according to the method described previously for SpaC antiserum-mediated inhibition 3 
of mucus-binding (18).  Briefly, a metabolically radiolabeled (3H) L. rhamnosus GG cell 4 
suspension was preincubated with each of the SpaCBA pilin-specific antiserum diluted 1:100, 5 
a 100 ?l volume added to microtiter plate wells coated with human colonic mucus (49), and 6 
allowed to incubate for 1 h at  37°C.  Each of the wells was then washed twice with PBS to 7 
rinse away cells adhering weakly to the mucosal substrate.  The cells remaining bound to the 8 
immobilized mucus were resuspended in a 1% SDS/0.1N NaOH solution, incubated for 1h at 9 
60°C, and the lysed cell suspension then assessed for radioactivity by liquid scintillation 10 
counting.  Mucosal adhesion was estimated as a percent ratio of the measured radioactivities 11 
for the lysed cell suspension and the cell suspension added initially to the wells. 12 
 13 
Statistical Analysis.  The linear association between the amount of unlabeled pilin protein (0, 14 
100, 300, and 900 pmol) and the measured amount (fmol) of radiolabeled pilin protein (125I) 15 
was tested to assess the dose-dependent pattern of inhibition for mucus binding by means of 16 
the Pearson product-moment correlation coefficient (t = -4.05 and n = 16 for SpaB, t = -2.88 17 
and n = 14 for SpaF, and t = -6.42 and n = 16 for SpaC).  The unequal variance t-test and the 18 
Bonferroni multiple comparison test were used to evaluate the significant difference in 19 
amounts of bound radiolabeled pilin protein (125I) or L. rhamnosus GG cells (3H) between 20 
measured samples. 21 
 22 
 23 
 24 
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RESULTS 1 
 2 
Production and purification of recombinant SpaCBA and SpaFED pilins.  The spaA, 3 
spaB, spaD, spaE, and spaF genes were each amplified by PCR from L. rhamnosus GG using 4 
the cloning primers listed in Table 1 and the respective PCR products cloned in a pET28b+ 5 
expression vector as described in Materials and Methods.  Recombinant pilins with C-6 
terminal hexahistidine-tagging were produced intracellularly in E. coli and purified by Ni2+-7 
agarose affinity chromatography.  Purified SpaA and SpaB pilins were used to produce SpaA- 8 
and SpaB-specific antibodies in rabbits (see Materials and Methods for details), and all 9 
purified SpaCBA and SpaFED pilin proteins were analyzed for adherence to intestinal mucus.  10 
The cloning, production, and purification of the SpaC minor pilin as well as its use to generate 11 
SpaC antiserum have been described previously (18).  The molecular weights for each of the 12 
purified recombinant pilin proteins (SpaA, SpaB, SpaC, SpaD, SpaE, and SpaF) 13 
corresponding to bands detected by SDS-PAGE (Fig. 1) were in agreement with calculated 14 
molar masses (Table 2).  An examination of the additional properties of the pilin subunits 15 
(Table 2) also revealed the highest isoelectric point (pI ~8) for the SpaB pilin.  Interestingly, 16 
SDS-PAGE of purified recombinant SpaB pilin (Fig. 1; lane 2) indicated the presence of a 17 
weakly stained high molecular weight protein band of unknown origin, but possibly 18 
representing an aggregate form of SpaB caused by SDS-induced precipitation.  Since strongly 19 
alkaline proteins (e.g., pI ~11) tend to precipitate in the presence of SDS at a pH below their 20 
isoelectric point, the extent of which is related to how positive charged the protein is at a 21 
particular pH (29) and that sometimes manifests as an anomalous SDS-PAGE migration 22 
pattern (7), a moderately alkaline SpaB protein might be prone to similar behavior.  As well, 23 
the reason for a doublet band of purified SpaA pilin (Fig. 1; lane 1) that would appear 24 
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occasionally on SDS-gels is unknown, but might be related to intramolecular isopeptide bonds 1 
identified previously for maintaining rigidity in the pilin structure (6, 16, 17) and whose 2 
altered formation possibly causes pilin proteins to migrate aberrantly when analyzed by SDS-3 
PAGE (41). 4 
 5 
Mucus-binding properties of the SpaCBA and SpaFED pilins.  In our previous work, we 6 
established binding between the SpaC minor pilin and human intestinal mucus using 7 
radiolabeled protein (18).  In this present study, we used the same approach to assess the 8 
mucus-binding properties of the predicted major pilin (SpaA and SpaD) and minor pilin 9 
(SpaB, SpaE, and SpaF) subunits associated with the two pilus gene clusters in L. rhamnosus 10 
GG.  Recombinant forms of the pilin subunits were purified, radiolabeled with iodine-125 11 
(125I), and screened for binding to human colonic mucus.  The SpaC minor pilin was included 12 
as a positive control in the binding analysis.  As shown in the mucus-binding profile for the 13 
SpaCBA and SpaFED pilins (Fig. 2), only the SpaB, SpaC, and SpaF subunits exhibited 14 
significant binding to the mucosal substrate.  Since the remaining three pilin subunits (SpaA, 15 
SpaD, and SpaE), all of which are predicted to contribute to the structural integrity of the 16 
pilus and lack discernible homology to recognized mucus-specific adhesins had displayed 17 
mucus binding below the background level, the absence of appreciable adherence to mucus 18 
was  not  completely  unexpected.   However,  the  two  minor  pilin  subunits  (SpaC  and  SpaF),  19 
which were predicted to be localized at the tip of different pilus fibers and prototypically 20 
adhesive in nature, had demonstrated an anticipated mucus-binding profile.  Since the SpaB 21 
minor pilin subunit shares similar predicted roles with the SpaA, SpaD, and SpaE pilins (see 22 
above), binding between the SpaB subunit and intestinal mucus was an unforeseen result.  23 
Moreover, the amount of mucus binding by the SpaB subunit was approximately seven-fold 24 
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 15
more  than  measured  for  the  SpaF and  SpaC pilins.   Since  of  the  six  SpaCBA and SpaFED 1 
pilin subunits only the SpaB minor pilin is a positive charged protein (Table 2), the binding 2 
between the SpaB pilin and negative charged mucosal moieties might be mediated simply by 3 
electrostatic interactions and independent of a specific mucus-binding domain.    Nonetheless, 4 
the two minor pilins (SpaB and SpaF) with measurable adherence to mucus were included in a 5 
competitive mucosal adhesion assay for additional characterization. 6 
 7 
Competitive mucosal adhesion of the SpaB and SpaF minor pilins.  To assess whether the 8 
mucosal adhesion interaction for the SpaB and SpaF pilin subunits can be inhibited in a dose-9 
related manner as reported for the SpaC minor pilin (18), we performed in vitro competitive 10 
binding experiments (Fig. 3) using radiolabeled proteins and intestinal mucus as described in 11 
Materials and Methods.  Both radiolabeled SpaC pilin (positive) and ovalbumin (background) 12 
were included as controls in the competitive binding assay.  Each of the radiolabeled pilin 13 
subunits (SpaB, SpaF, and SpaC) bound to the mucus substantially more than the background 14 
control (Figs. 3A, 3B, and 3C).  Moreover, supported by a statistical analysis of the binding 15 
data for all three pilin subunits, competing amounts of unlabeled proteins (100, 300, and 900 16 
pmol) caused an apparent dose-related inhibition of mucus binding, although the SpaB 17 
subunit demonstrated the most convincing dose-related reduction in adhesion (Fig. 3A).  The 18 
results we obtained here are in agreement with competitive adhesion binding. 19 
 20 
The influence of electrostatic interactions on the mucus-binding specificity of the SpaB 21 
minor pilin.  To determine whether electrostatic interactions influence the mucus-binding 22 
specificity of the basic SpaB pilin protein, we used positive charged lysozyme (pI ~11) to 23 
inhibit the mucosal adhesiveness of SpaB pilin.  In a previous study (14), it was reported that 24 
 at W
ageningen UR Library on February 24, 2010 
a
e
m
.a
sm
.o
rg
D
ow
nloaded from
 
 16
lysozyme can crosslink mucus by electrostatic means and, in doing so, contribute partially to 1 
the build-up of the macromolecular gel-like nature of mucus.  As controls, we included the 2 
effect of adding unbound mucus and performed the binding experiment with the SpaC minor 3 
pilin.  Binding of SpaB pilin to intestinal mucus was diminished by approximately 50% in the 4 
presence of lysozyme (2.5 µg/µl), indicating that lysozyme competes with SpaB pilin for 5 
mucus and electrostatic interactions may play some part in SpaB-mediated mucosal adhesion 6 
(Fig. 4).  As expected near saturating quantities of unbound mucus abolished a significant 7 
portion of binding between the SpaB pilin and bound mucus (Fig. 4).  For the SpaC minor 8 
pilin, mucus binding was reduced by about two-fold in the presence of additional mucus and 9 
unaffected by large amounts of lysozyme. 10 
 11 
Inhibition of L. rhamnosus GG mucosal adhesion by pilin-specific antibodies.  12 
Previously, the presence of cell surface-localized intact pili, encoded by the spaCBA gene 13 
cluster, including their capacity for mucus binding and the inhibition thereof have been 14 
demonstrated in L. rhamnosus GG using antiserum specific for the SpaC minor pilin (18).  As 15 
a means to characterize the mucosal adherence properties of SpaCBA pili further, we 16 
examined the effect of pretreating L. rhamnosus GG cells with SpaB antiserum.  As controls, 17 
untreated cells and cells pretreated with SpaA- and SpaC-specific antibodies were also 18 
included.  Mucosal adhesion by the untreated cells was detected as anticipated and the 19 
pretreatment of cells with SpaC antiserum confirmed our earlier findings (18). 20 
 21 
Pretreatment with SpaB antiserum had surprisingly failed to block mucosal adhesion (Fig. 5) 22 
despite the demonstration of significant mucus binding by the recombinant SpaB pilin (Fig. 2) 23 
and the functionality of the SpaB-specific antibodies as indicated by their use in identifying 24 
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surface-localized SpaCBA pilus fibers by immunogold-labeled electron microscopy (J. 1 
Reunanen et al., to be published).  The spaB gene in the spaCBA pilus gene cluster has been 2 
predicted previously as an ancillary minor pilin (18) and, according to a current model of 3 
pilus assembly (27), likely corresponds to the same type of pilin subunit deposited at the pilus 4 
base and sparingly along the pilus backbone and implicated in signaling the cessation of pilus 5 
polymerization.  Consequently, the binding of SpaB-specific antibodies to SpaB localized 6 
similarily in the SpaCBA pilus structure may only prevent SpaB-mediated mucus adhesion 7 
and thus impose little steric hindrance that would affect the mucus-binding capacity of the 8 
SpaC pilin.  This rationale was borne out when cells pretreated with both SpaB and SpaC 9 
antiserum could no longer adhere to mucus (Fig. 5).  Mucus binding appears to have been 10 
blocked for the most part by the SpaC-specific antibody, reflecting the possibility that the 11 
SpaB pilin in assembled pilus fibers contributes less to L. rhamnosus GG mucosal adhesion 12 
than deduced from the high level of mucus binding for the individual SpaB pilin subunit (Fig. 13 
2). Moreover, since each type of pilin is situated primarily in a different location within the 14 
pilus structure, a SpaC pilin at the tip of a pilus fiber (18) may be more accessible to mucosal 15 
substrates than a SpaB pilin in its predicted position at the pilus base. 16 
 17 
Another unexpected result was the five-fold reduction in mucus binding by the cells 18 
pretreated with SpaA antiserum (Fig. 5) even though the SpaA pilin subunit did not adhere 19 
appreciably  to  intestinal  mucus  (Fig.  2).   However,  because  the  SpaA  major  pilin  is  the  20 
predicted predominant subunit comprising the pilus backbone (18), the pili-bound SpaA-21 
specific antibodies may simply hinder sterically the SpaC pilin subunits shown to be 22 
deposited at the pilus tip and intermittently throughout the SpaCBA pilus (18), and therefore 23 
cause obstruction of SpaC-mediated mucosal adhesion. 24 
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 1 
DISCUSSION 2 
 3 
The continuous shedding of intestinal epithelial cells and the peristaltic movement of food and 4 
water through the intestine create a dynamic environment with considerable challenges for 5 
stable bacterial colonization of the gastrointestinal tract (52).  Since a sizeable portion of the 6 
intestinal microbiota coexists symbiotically with the host, it is advantageous that the intestine 7 
encompass an environmental niche favoring localized commensal growth.  The mucus gel 8 
layer, which spans the epithelial cell lining of the inner intestinal walls, is naturally the first 9 
region for possible microbial contact and attachment, and can provide an environment 10 
comprised of a conserved glycan-based matrix for localizing microbes, binding sites to 11 
prevent microbial washout from the intestine, and a carbohydrate-rich source of nutrients (34, 12 
52).  Within the intestinal microbiota, a diverse range of commensal, probiotic, and 13 
pathogenic species have adapted to a mucosal milieu by developing unique surface-associated 14 
features with mucus-related specificity (2). 15 
 16 
The prevailing consensus about what constitutes an effective probiotic follows the general 17 
rule that these types of bacteria must have an inherent ability for maintaining persistent 18 
growth in the GI tract (9, 59).  However, several studies using various probiotic strains have 19 
reported that rather than becoming one of the fortified species of the intestinal microbiota, the 20 
probiotics are allochthonous, existing transiently and requiring constant replenishing to persist 21 
for extended periods in the intestine (3, 5, 10, 59).  Moreover, studies have also revealed 22 
variations in the level of intestinal persistence between many probiotic bacteria (13, 18).  23 
Although some debate continues whether persistent colonization is essential for the beneficial 24 
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immunomodulating effects of probiotics (9), lactobacilli bacteria must still rely on specific 1 
adherence mechanisms for displacing pathogens and preventing their own immediate washout 2 
from  the  intestinal  tract.   Nonetheless,  a  plethora  of  studies  have  demonstrated  binding  3 
between a variety of probiotic Lactobacillus spp. and mucus-related substrates (23), but very 4 
few have pinpointed either by genomic or proteomic means those cell surface components 5 
directly responsible for mucosal adhesion.  In our recent study (18) we reported the presence 6 
of elongated pilus fibers on the cell surface of the probiotic L. rhamnosus GG strain.  7 
Moreover, we attributed a mucus-binding capacity to these pili (encoded by the spaCBA gene 8 
cluster), and in particular, to one of the individual pilin subunits (SpaC) constituting the pilus 9 
fiber.  Such pili, by virtue of their long and slender appendaged architecture, an observed 10 
propensity to tether around the cell exterior, and a binding specificity for mucus are ideal 11 
surface structures for ensuring microbes remain attached and embedded within a mucosal 12 
matrix.  Consequently, the L. rhamnosus GG strain, which has been characterized as an 13 
effective probiotic is expected to have a distinct advantage over nonpiliated probiotic 14 
lactobacilli for maintaining an extended or stable residency in the GI tract.   15 
 16 
The structural constituents of the two pilus fibers (SpaCBA and SpaFED) encoded within the 17 
genome of L. rhamnosus GG  include  one  major  pilin  and  two  minor  pilin  subunits,  all  of  18 
which resemble prototypically those structural components of pili found in many other Gram-19 
positive bacteria (26, 40, 49).  So far, only the SpaC minor pilin subunit from the SpaCBA 20 
pilus has been assessed for a binding specificity (18), leaving five predicted pilus components, 21 
the SpaA and SpaD major pilin and the SpaB, SpaE, and SpaF minor pilin subunits, 22 
uncharacterized.  In this study, we cloned the corresponding genes (spaA, spaB, spaD, spaE, 23 
and spaF), produced and purified recombinant forms of pilin protein, and undertook a 24 
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systematic assessment of their respective binding specificity for human intestinal mucus.  1 
Following the initial screen for mucus-binding properties, we observed no appreciable 2 
mucosal adhesion with the SpaA, SpaD, and SpaE pilin subunits, a somewhat expected result 3 
with hindsight when the predicted roles of these components in an assembled pilus fiber and 4 
the lack of mucosal-related binding domain homologs in each of their primary structures are 5 
taken into account (18).  Although pilin subunits from some Gram-positive bacteria show 6 
adherence to the extracellular matrix (ECM) proteins underlying the intestinal epithelium 7 
(11,21,51), our own attempts to screen for similar binding specificities with the three pilin 8 
subunits unable to adhere to mucus were largely unsuccessful (data not shown).  At present, 9 
major  pilin  subunits  comprising  the  pilus  backbone  and  minor  pilin  subunits  located  at  the  10 
pilus base of other Gram-positive pili have not demonstrated specific adhesion properties (20, 11 
26, 40, 49).  However, for the SpaB and SpaF minor pilins, each showed significant 12 
adherence to the mucosal substrate, and in a competitive adhesion assay the inhibition of 13 
mucus binding was dose-related, with the best dose-dependent reduction in adhesion 14 
displayed by the SpaB pilin.  Considering that SpaF pilin is one of the two large-sized pilus 15 
components (see Table 2) and correspondingly a predicted adherent tip pilin, a mucus binding 16 
capacity could be conceivably anticipated.  Previously, we described the presence of a von 17 
Willebrand factor-like domain with possible lectin-type binding character in the primary 18 
structure of the SpaC pilin (18), but for the SpaF pilin similar or related domain homologies 19 
were not observed.  Although pilus fibers encoded by the spaFED gene cluster have yet to be 20 
identified on the surface of L. rhamnosus GG cells, our results suggest that only one of the 21 
three pilin subunits (SpaF) in an assembled pilus structure would possess a mucus-binding 22 
specificity. 23 
 24 
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The detection of binding between the SpaB minor pilin and intestinal mucus, which was 1 
considerably more than measured for the SpaF and SpaC pilins was a rather surprising 2 
outcome in the absence of any homology to established mucus-specific adhesins (18).  When 3 
the physical and chemical properties of the six pilin subunits were compared, we found that 4 
the isoelectric point for the SpaB pilin (pI ~8) was higher than the five other pilins (pI ~5), 5 
and resultingly, we investigated whether electrostatic interactions have a role in SpaB-6 
mediated mucosal adhesion.  Several reports in the literature have described the use of high 7 
ionic strength (1M NaCl) to disrupt charge-dependent bonds and thereby establish charge 8 
mechanisms for a varied array of protein-mediated interactions (4, 35, 50).  However, we 9 
instead chose to use large amounts of a positive charged protein to inhibit binding between the 10 
SpaB pilin and mucus.  Lysozyme, a highly positive charged enzyme (pI ~11) that is found 11 
normally at basal levels throughout the intestinal tract (37) and possibly forms crosslinks with 12 
mucus by electrostatic bonding (14), was able to compete with the SpaB pilin for the negative 13 
charged mucosal substrate.  Since SpaB pilin-mediated mucosal adhesion was inhibited 14 
effectively by lysozyme, the binding determinants between SpaB pilin and mucus may likely 15 
be governed by electrostatic contacts, and therefore, as proposed for lysozyme, the SpaB pilin 16 
may have the same capacity to crosslink with mucus.  Moreover, given that the SpaC tip pilin 17 
is also deposited occasionally throughout the pilus fiber (18) as is predicted for SpaB, their 18 
frequency of incorporation within the SpaCBA pilus fiber will have a direct influence on the 19 
overall strength of L. rhamnosus GG mucosal adhesion.  Previously, we had established the 20 
contribution of the SpaC component to SpaCBA pili-mediated mucosal adhesion by 21 
pretreating L. rhamnosus GG cells with SpaC-specific antiserum (18).  In our present study, 22 
the results from a similar experiment using SpaB antiserum were inconclusive and did not 23 
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confirm directly an involvement of the SpaB pilin mucus-binding capacity in the assembled 1 
SpaCBA pilus fibers.    2 
 3 
We have now given a further insight into the binding specificities of the major and minor pilin 4 
subunits for the pilus fibers encoded by the L. rhamnosus GG spaCBA and spaFED gene 5 
clusters.  In a continuation of our earlier work, we have now shown that two pilin components 6 
binding to mucus, one possibly in a lectin-type manner (SpaC) (18) and another through 7 
electrostatic contacts (SpaB) are conceivably involved in SpaCBA pili-mediated adherence to 8 
intestinal mucus.  Moreover, we have established that the SpaF minor pilin would be the only 9 
mucus-binding component in the putative SpaFED pilus fiber.  Several studies have reported 10 
that various Gram-positive pathogens use mucosal adhesion for facilitating their invasive 11 
colonization of the GI tract (reviewed in 53).  Our report of pilus fibers in the L. rhamnosus 12 
GG strain with such an evident mucus-binding predisposition lends support to the well-13 
recognized mechanism by which probiotics displace pathogenic bacteria using competitive 14 
elimination or steric hindrance (8, 12, 24, 43).  Since the intestinal mucosal barrier is a 15 
nonhomogeneous collection of various protein- and carbohydrate-rich components, some 16 
might represent potential receptor-binding sites that adhere specifically to the pilus fibers in L. 17 
rhamnosus GG.  By using the three recombinant mucus-binding pilin subunits (SpaB, SpaC, 18 
and SpaF), we plan to identify, isolate, and characterize the equivalent host cell receptors 19 
located within the intestinal mucosa as part of our future studies.  Presently, three-dimensional 20 
(3-D) structure determination of the major and minor pilin subunits has been described for 21 
four piliated Gram-positive species (6, 16, 17, 22), and so the availability of soluble and 22 
functional L. rhamnosus GG pilin proteins will now facilitate obtaining additional structural 23 
insight into the assembly and function of pilus fibers from a probiotic strain. 24 
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FIGURE LEGENDS 1 
 2 
FIG. 1.  Purified recombinant SpaCBA and SpaFED pilin proteins.   3 
Purified recombinant SpaA (lane 1), SpaB (lane 2), SpaC (lane 3), SpaD (lane 4), SpaE (lane 4 
5), and SpaF (lane 6) pilin proteins were separated using 12% SDS-PAGE followed by 5 
staining with coomassie brilliant blue R-250.  Molecular weight standards (kDa) and the 6 
location of the pilin protein bands are as indicated. 7 
 8 
FIG. 2.  Adherence of SpaCBA and SpaFED pilin proteins to human intestinal mucus.  9 
The determination of binding between the 50 pmol radiolabeled (125I) SpaCBA and SpaFED 10 
pilins and immobilized mucus, and the corresponding statistical analysis are described in 11 
Materials and Methods.  The background level of mucus binding was based on 50 pmol 12 
radiolabeled (125I) ovalbumin adherence to mucus.  Binding data from three to four 13 
measurements are given as mean ± SD and the dataset comparisons are considered significant 14 
(P?? 0.05).  15 
 16 
FIG. 3.  Competitive mucus-binding of the SpaB and SpaF minor pilins.  The inhibition 17 
of mucus binding by 50 pmol radiolabeled (125I) SpaB (A), SpaF (B), and SpaC (C) pilins was 18 
carried out with competing amounts of the respective unlabeled pilin subunit (0, 100, 300, and 19 
900 pmol) as described in Materials and Methods.  Binding between 50 pmol radiolabeled 20 
(125I) ovalbumin and immobilized mucus indicated the level of background mucus binding.  21 
Binding data are mean values ± SD from three to four measurements.  The dataset 22 
comparisons and dose-related inhibition of mucus binding are considered significant (P? ? 23 
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0.01) for each SpaB, SpaF, and SpaC pilin subunit.  Further details on the statistical analysis 1 
are provided in Materials and Methods. 2 
 3 
FIG. 4.  Inhibition of binding between SpaB minor pilin and mucus. 4 
The effect of 2.5 ug/ml lysozyme or unbound intestinal mucus on the adherence of 50 pmol 5 
radiolabeled (125I) SpaB and SpaC pilins to immobilized mucus was determined using the 6 
procedure provided in Materials and Methods.  Binding data obtained from three to four 7 
measurements are presented as mean ± SD and the dataset comparisons are considered 8 
significant (P?? 0.05).  Further information on the statistical analysis is provided in Materials 9 
and Methods. 10 
 11 
FIG. 5.  SpaCBA pilin antibody-mediated inhibition of L. rhamnosus GG mucosal 12 
adhesion. 13 
Radiolabeled (3H) L. rhamnosus GG cells were pretreated with SpaA-, SpaB-, and SpaC-14 
specific antiserum and examined for mucus binding as described in Materials and Methods.  15 
Binding data from six measurements are given as mean ± SD and the dataset comparisons are 16 
considered significant (P? ? 0.05).  Additional information on the statistical analysis is 17 
described in Materials and Methods. 18 
 19 
 20 
 21 
 22 
 23 
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TABLE 1.  Oligonucleotide primers used for PCR cloning a 1 
________________________________________________________________________________ 2 
 3 
Gene  ORF    Oligonucleotide primer sequences b 4 
________________________________________________________________________________ 5 
 6 
spaA  LGG_00442 f-5'-TCGGGTTCAGAATTCTACGAATGATACGAC 7 
    r-5'-TGCCAGTACCACCCTCGAGTGGCAGAATAC  8 
spaB  LGG_00443 f-5'-GCAGACACAGAATTCAACTGTGCCGACC 9 
    r-5'-CAACTGTATCACCCTCGAGTGGCAACAATTGACG 10 
spaD  LGG_02370 f-5'-ACCCGTACAGAATTCGACAACGACTGTG 11 
    r-5'-GTCCGATTCCGCCCTCGAGCGGCAATAATTG 12 
spaE  LGG_02371 f-5'-CCACATTGGGTTCAGAATTCTGATCAAACTG 13 
    r-5'-TGCGCCAATCGGACTCGAGCGGCAAATAAC 14 
spaF  LGG_02372 f-5'-GCAAATTGGCAGGAGCTCGGTCCCGGTAG 15 
    r-5'-CCGCTACCACCCTCGAGCGGTAGGAGTG 16 
________________________________________________________________________________ 17 
a Oligonucleotide primers were designed using the L. rhamnosus GG genome sequence (18). 18 
b Sequences for restriction endonucleases to facilitate cloning, EcoRI (and SacI for spaF) in the 19 
forward (f) and XhoI in the reverse (r) oligonucleotide primers, are underlined and in boldfaced type. 20 
 21 
 22 
 23 
 24 
 25 
 26 
 27 
 28 
 29 
 30 
 31 
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TABLE 2.  Properties of the recombinant SpaCBA and SpaFED pilin proteins 1 
___________________________________________________________________________ 2 
 3 
Pilin  Molar mass (kDa) Amino acid length Isoelectric point (pI) 4 
___________________________________________________________________________ 5 
 6 
SpaA    31   283   5.1 7 
SpaB    21   188   8.0 8 
SpaC    91   836   5.0 9 
SpaD    51   465   5.5 10 
SpaE    45   400   5.9 11 
SpaF   104   943   5.4 12 
___________________________________________________________________________ 13 
 14 
 15 
 16 
 17 
 18 
 19 
 20 
 21 
 22 
 23 
 24 
 25 
 26 
 27 
 28 
 29 
 30 
 at W
ageningen UR Library on February 24, 2010 
a
e
m
.a
sm
.o
rg
D
ow
nloaded from
 
 38
Fig. 1 
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Fig. 2 
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Fig. 3 
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Fig. 4 
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Fig. 5 
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